Kynd Stress Relief Tablets 30s

Official notice

5 May 2022

Last checked

5 May 2022

High riskACCC

An official ACCC notice concerns Kynd Stress Relief Tablets 30s. Allergic reactions often present as a skin rash or itchiness. However, some people may experience more severe allergic reactions such as difficulty breathing or anaphylaxis, and may require medical treatment. Published 2022-05-05.

What to do now

Consumers who have a bottle of Kynd Stress Relief Tablets from batch 106585 should not use it and should return it to the place of purchase for a refund. Consumers who are concerned about use of this product should consult their doctor. For more details, see https://apps.TGA.gov.au/Prod/sara/arn-detail.aspx k=RC-2022-RN-00589-1 For further information, please contact iNova customer service by phone on 1800 630 056 (Option 1) or via email at customerservice@inovapharma.com

Recall number

efc0da75-ed88-4f10-a467-388138631211

Official notice

2022-05-05

The hazard

Allergic reactions often present as a skin rash or itchiness. However, some people may experience more severe allergic reactions such as difficulty breathing or anaphylaxis, and may require medical treatment.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

es, 106585

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Kynd Stress Relief Tablets 30's Ashwagandha 6000mg + B Vitamin Complex + Magnesium Tablets Batch Number: 106585 Expiry Date: Aug 2023 ARTG: AUST L 371735 Complementary medicine containing Ashwagandha ( Withania somnifera ), magnesium and Vitamin B complex to help decrease symptoms of mild anxiety No other batches of Kynd Stress Relief Tablets are affected by this recall

Risk / hazard

Allergic reactions often present as a skin rash or itchiness. However, some people may experience more severe allergic reactions such as difficulty breathing or anaphylaxis, and may require medical treatment.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

AU · Australia

Affected area 1

AU · Australia

Source & status

Source

Tier

beta

Category

HOME

Classification

Pharmacy and medical products

App estimate

high

Recall details

Recall number

efc0da75-ed88-4f10-a467-388138631211

Classification

Pharmacy and medical products

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 5 May 2022. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.